| 000 | 00941 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516140004.0 | ||
| 264 | 0 | _c20140310 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1098-9064 | ||
| 024 | 7 |
_a10.1055/s-0033-1334488 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVercauteren, Ellen | |
| 245 | 0 | 0 |
_aThrombin activatable fibrinolysis inhibitor: a putative target to enhance fibrinolysis. _h[electronic resource] |
| 260 |
_bSeminars in thrombosis and hemostasis _cJun 2013 |
||
| 300 |
_a365-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarboxypeptidase B2 _xchemistry |
| 650 | 0 | 4 | _aFibrinolysis |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aGils, Ann | |
| 700 | 1 | _aDeclerck, Paul J | |
| 773 | 0 |
_tSeminars in thrombosis and hemostasis _gvol. 39 _gno. 4 _gp. 365-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0033-1334488 _zAvailable from publisher's website |
| 999 |
_c22549810 _d22549810 |
||